Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.

• Status: Completed
• Trial end date: 2007-01-01

Summary

The purpose of this study is to assess if 10 mg Bay 59-7939, taken once daily as a tablet, is safe and prevents blood clot which may form after a knee replacement operation.

• Phase: Phase 3

Details

• Lead Sponsor: Bayer
• Treatments: Enoxaparin; Rivaroxaban